|
|
EQS GroupMedia / 04.09.2020 / 19:00
Media Release
Medacta Announces Successful Completion of the First Australian Surgery with NextARTM TKA Augmented RealityBased Surgical Platform following TGA ApprovalCASTEL SAN PIETRO, 04 September 2020 Medacta announced today successful completion of the first surgery utilizing its NextARTM TKA, following recent approval from Australias Therapeutic Goods... Lire le communiqué |
|
| |
|
| |
|
|
EQS GroupMedia / 02.09.2020 / 19:00
Media Release
Medacta Receives FDA Clearance for the Lateralized Glenosphere
CASTEL SAN PIETRO, 02 September 2020 Medacta announced today that it has received clearance from the U.S. Food and Drug Administration FDA for its Lateralized Glenosphere. This implant, which received the CE marking in 2019, further expands the Medacta offering for shoulder... Lire le communiqué |
|
| |
|
| |
|
|
EQS GroupAdhoc: Medacta Group SA / Key words: Half Year Results
Medacta Halfyear 2020 revenue equal to Euro 135M, down 11.1% over the prior year due to COVID19 related deferrals of orthopedic elective surgeries. Good backlog recovery in June with a doubledigit growth rate.
22Jul2020 / 07:00 CET/CEST
Release of an ad hoc announcement pursuant to Art. 53 KR
The issuer is solely responsible for... Lire le communiqué |
|
| |
|
| |
|
|
EQS GroupAdhoc: Medacta Group SA / Key words: Regulatory Approval
Medacta to Introduce NextARTM: First FDACleared Augmented RealityBased Surgical Platform for Total Knee Replacement
13Jul2020 / 07:00 CET/CEST
Release of an ad hoc announcement pursuant to Art. 53 KR
The issuer is solely responsible for the content of this announcement.
Press ReleaseMedacta to Introduce NextARTM: First... Lire le communiqué |
|
| |
|
| |
|
|
EQS GroupMedia / 30.06.2020 / 21:00
Media Release
Medacta Announces First Hip Replacement Surgeries with New QuadraP System Following Successful FDA Clearance and CE Marking
CASTEL SAN PIETRO, 30 June 2020 Medacta announced today the first surgeries in the U.S. and Europe with its new QuadraP Collared and QuadraP Cemented femoral stems following recent clearance from the U.S. Food and Drug... Lire le communiqué |
|
| |
|
| |
|
|
EQS GroupMedia / 03.06.2020 / 19:30
Media release
Medacta Receives CE Marking for its Long Diaphysis and Stemless Metaphysis Implants for Shoulder Joint Replacement
CASTEL SAN PIETRO, 03 June 2020 Medacta today announced it has obtained CE marking for its Long Humeral Diaphysis and Stemless Humeral Metaphysis implants for shoulder joint replacement.
Long Humeral Diaphysis and Stemless... Lire le communiqué |
|
| |
|
| |
|
|
EQS GroupMedia / 28.05.2020 / 19:15
Media ReleaseMedacta Announces First Surgery Utilizing MectaC Stand Alone Anterior Cervical Interbody Fusion Device and New Registrations
CASTEL SAN PIETRO, 28 May 2020 Medacta announced today the first surgery utilizing its recently FDAcleared MectaC Stand Alone platform for anterior cervical discectomy and fusion procedures ACDF. After obtaining the FDA... Lire le communiqué |
|
| |
|
| |
